— Know what they know.
Not Investment Advice
Also trades as: IVX.AX (ASX) · $vol 0M

IVIXF OTC

Invion Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -88.3% 5Y: -96.4%
$0.04
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 39 · $4.0M mcap · 66M float · 0.0000% daily turnover

Income Trends

Revenue
$266K +0.0% ▲
5Y CAGR: -31.4%
Gross Profit
-$925K -9.0% ▼
Operating Income
-$4M -12.6% ▼
Net Income
-$4M +32.8% ▲
EPS (Diluted)
$-0.04 +46.2% ▲
EBITDA
-$3M -3.7% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$2M$3M$2M$0$266K
YoY Growth+29.8%+20.4%-9.9%-100.0%+0.0%
Cost of Revenue$2M$2M-$1M$849K$1M
Gross Profit$669K$804K$4M-$849K-$925K
Gross Margin29.5%29.4%150.0%—-347.7%
R&D Expenses$2M$2M$3M$849K$1M
SG&A Expenses$2M$1M$2M$2M$2M
Operating Expenses$4M$3M$6M$3M$3M
Operating Income-$2M-$1M-$4M-$3M-$4M
Operating Margin-70.5%-40.2%-153.7%—-1472.2%
Interest Expense$0$0$0$457K$240K
Income Before Tax-$2M-$1M-$4M-$6M-$4M
Tax Expense$0$0$0$0$0
Net Income-$2M-$1M-$6M-$6M-$4M
Net Margin-68.1%-39.3%-228.5%—-1464.2%
EPS (Diluted)$-0.03$-0.02$-0.06$-0.08$-0.04
EBITDA-$1M-$641K-$3M-$3M-$3M
Shares Outstanding61M64M64M72M90M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms